Required minimum distributions (RMDs) are the minimum amounts you must withdraw from your retirement accounts each year. You generally must start taking withdrawals from your …

Minimal residual disease (MRD), also known as molecular residual disease, or measurable residual disease, is the medical condition in which small number of cancer cells persist in a …

Jul 15, 2020 · Minimal residual disease (MRD) is common in patients with blood cancers, such as leukemia, lymphoma and multiple myeloma. But what does this mean for patients and their …

Jul 1, 2025 · Learn how physicians use this crucial tool in modern oncology to improve patient outcomes. Minimal residual disease (MRD) testing is a critical tool for assessing the long-term …

Dec 11, 2025 · CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma. During the 2025 American Society of Hematology annual meeting, held …

Mar 17, 2022 · Learn all about minimal residual disease (MRD), how doctors test for it, what your results may mean, and what you can do next.

Nov 20, 2024 · Measurable or minimal residual disease (MRD) testing is used to see if the cancer treatment is working and to guide further treatment plans. MRD testing is mainly used in blood …

Minimal residual disease (MRD, also referred to as measurable residual disease) is the term for very small numbers of cancer cells that a patient retains after treatment.

Mar 31, 2025 · Measurable Residual Disease, sometimes called Minimal Residual Disease or MRD, refers to the small number of myeloma cells that may remain after treatment, even when …

Minimal (or measurable) residual disease (MRD) findings have been shown in numerous studies to correlate strongly with clinical outcomes in the posttherapy setting.